The company specializes in designing and developing personalized molecular diagnostic tools for clinical laboratories, pharmaceutical companies, physicians, patients, and researchers. Their products include PCR-based reagents and controls for gene rearrangement, chromosome translocation, and gene mutation testing. Invivoscribe's CE-marked IVD products target biomarkers with demonstrated clinical utility, and their companion diagnostic products assist in the development of pharmaceutical agents and devices. With a focus on improving healthcare worldwide, Invivoscribe's gene rearrangement and gene mutation testing products are covered by exclusive-licensed patents.